Skip to Main Content
TRC_Prescriber's Letter NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • GO TO CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Bone & Joint
  4. Other

Other

  • Fibromyalgia (22)
  • Fractures (10)
  • Gout (26)
  • Lupus (2)
  • Musculoskeletal (18)
  • Orthopedics (10)
  • Osteoarthritis (78)
  • Osteopathy (2)
  • Osteoporosis (153)
  • Other (24)
  • Resources (156)
  • Rheumatoid Arthritis (59)
16 - 24 of 24 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: A new version of oral diclofenac for pain called Zorvolex (ZOR-voh-lex) will hit the market February 2014
Article: methicillin-resistant Staph aureus (MRSA) infections in hospitalized patients March 2011
Chart: Drug Therapy for Methicillin-Resistant Staph Aureus (MRSA) March 2011
Guideline: Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children (January 2011) February 2011
Patient Education: What I Need to Know About My Rheumatoid Arthritis Medication August 2009
Article: Simponi (SIM-po-nee), a new tumor necrosis factor (TNF) blocker for rheumatoid arthritis June 2009
Guideline: Use of Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (2008) June 2009
Commentary: Simponi (Golimumab): A Monthly Injectable Drug for Arthritis June 2009
Article: concern over the safety of Celebrex in children February 2007
  • « Prev
  • 1
  • 2
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved